Overview

Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed Condition

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
To characterise the pharmacokinetic profile of sponsor's test formulation Isotretinoin Capsules 40 mg in comparison to the reference formulation Amnesteem (Containing Isotretinoin) Capsules 40 mg after single oral dose administration to healthy, normal, adult, human male subjects under fed condition.
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Isotretinoin